Syrotuik & Bell 2004: Creatine Responders vs Non-Responders

Fact-checked against peer-reviewed research · Our editorial policy
4 min read
This content is for educational purposes only and is not medical advice. Consult a healthcare provider before starting any supplementation.

Study Overview

Citation: Syrotuik DG, Bell GJ. (2004). Acute creatine monohydrate supplementation: a descriptive physiological profile of responders vs. nonresponders. Journal of Strength and Conditioning Research, 18(3), 610-617.

This study systematically characterised the physiological differences between individuals who respond well to creatine supplementation and those who show minimal response. It provided the first evidence-based framework for understanding individual variation in creatine uptake.

20-30%
Estimated percentage of individuals who show minimal response to creatine supplementation

Study Design and Methods

Eleven male participants underwent a standard 5-day creatine loading protocol (0.3g/kg/day). Muscle biopsies were taken before and after to directly measure changes in total creatine, free creatine, and phosphocreatine. Participants were classified as responders (greater than 20mmol/kg increase), quasi-responders (10-20mmol/kg increase), or non-responders (fewer than 10mmol/kg increase).

Additional physiological measures included muscle fibre type composition, cross-sectional area of fibres, initial muscle creatine content, and lean body mass.

Key Findings

Responder Characteristics

Responders tended to have lower initial muscle creatine content (more room for loading), greater proportion of Type II (fast-twitch) muscle fibres, larger muscle fibre cross-sectional area, and greater lean body mass.

Non-Responder Characteristics

Non-responders typically had higher baseline muscle creatine (already near saturation), greater proportion of Type I (slow-twitch) muscle fibres, smaller muscle cross-sectional area, and less lean body mass.

Type II fibres
Higher proportion of fast-twitch fibres predicted better creatine response

The Saturation Ceiling

Perhaps the most important finding was the concept of a saturation ceiling. Individuals whose muscles were already close to maximum creatine capacity showed less improvement because there was simply less room for additional creatine storage. This explains why vegetarians (with lower baseline stores) tend to show the greatest response.

(RB et al., 2017)

Practical Implications

  1. Most people respond well — 70-80% will see meaningful benefits
  2. Vegetarians are likely super-responders — Lower baseline means more room for improvement
  3. Give it adequate time — At least 4 weeks before concluding you are a non-responder
  4. Non-response does not mean harm — Creatine is still safe even if muscle uptake is limited
  5. Try loading first — A 5-7 day loading phase may help determine response status

Malaysian Relevance

For Malaysian gym-goers who try creatine and feel “nothing happened,” this research provides context. Try for at least 4 weeks, and if you eat a meat-heavy diet, you may already have relatively high baseline stores. Malaysian vegetarians (Hindu, Buddhist communities) are particularly likely to benefit significantly from creatine supplementation.

Sources and References

  • Syrotuik DG, Bell GJ. (2004). Acute creatine monohydrate supplementation: responders vs. nonresponders. JSCR, 18(3), 610-617.
  • Kreider RB, et al. (2017). ISSN position stand. JISSN, 14, 18.

Study Limitations

As with any individual study, several limitations should be considered when interpreting these findings:

  • Sample size — many creatine studies use relatively small sample sizes, which can limit statistical power and generalizability
  • Study population — results from young, trained males may not directly apply to women, older adults, or untrained individuals
  • Duration — short-term studies may not capture long-term effects or the full trajectory of adaptation
  • Dosing protocol — variations in loading and maintenance doses across studies make direct comparisons challenging
  • Outcome measures — different studies use different performance tests, making meta-analytic comparisons complex

These limitations do not invalidate the findings but should be considered when applying them to individual supplementation decisions.

What This Means for You

For the average creatine user, this research supports the following practical recommendations:

  1. Choose creatine monohydrate — it remains the most studied and effective form
  2. Take 3-5g daily — consistent daily dosing is more important than timing
  3. Take it with food — insulin response from meals enhances muscle uptake
  4. Be patient — full saturation takes 3-4 weeks without loading
  5. Combine with exercise — creatine works best when paired with resistance or high-intensity training

For more on practical dosing strategies, see our creatine dosage guide.

Study Design and Methodology

Understanding how a study was designed helps assess the strength of its conclusions. Key methodological factors to evaluate include:

  • Sample size — larger studies (n=50+) provide more reliable results than small studies (n=10-15). Small sample sizes increase the risk of false positives and limit the ability to detect moderate effect sizes
  • Study duration — creatine research requires adequate duration for muscle saturation (minimum 4 weeks for maintenance dosing, 1 week for loading). Studies shorter than this may miss the full effect
  • Blinding — double-blind, placebo-controlled designs (where neither researchers nor participants know who receives creatine) are the gold standard for minimising bias
  • Population studied — results from trained athletes may not fully apply to untrained individuals, and vice versa. Age, sex, and dietary habits (particularly vegetarian status) also influence creatine response
  • Outcome measures — direct measures (muscle biopsy, MRS imaging) are more informative than indirect proxies (blood markers, performance tests) for assessing creatine uptake and metabolism

Clinical Implications and Practical Relevance

This research contributes to our understanding of creatine in several practical ways:

For athletes and fitness enthusiasts: The findings support the use of creatine monohydrate as a safe, effective ergogenic aid. The standard dosing protocol of 3-5g daily remains well-supported by the cumulative evidence base including this study.

For healthcare professionals: Understanding the specific mechanisms and safety data from studies like this helps clinicians provide evidence-based guidance to patients who ask about creatine supplementation. The research consistently shows a favourable safety profile at recommended doses.

For the Malaysian context: While most creatine research is conducted in Western populations, the fundamental biochemistry (ATP-phosphocreatine system) is universal. Malaysian consumers can apply these findings with confidence, adjusting for local factors like tropical climate (increased hydration needs) and halal dietary requirements (synthetic creatine monohydrate is permissible).

How This Fits Into the Broader Evidence

No single study should be used to make definitive claims about creatine supplementation. Instead, this research should be viewed as one piece of a much larger evidence base:

For a complete overview of the evidence, explore our Research Library which covers 60+ landmark creatine studies.

Further Reading

Sources & References

Full citations available in our Research Library.

Frequently Asked Questions

Why does creatine not work for some people?

Syrotuik & Bell 2004 found that non-responders tend to have higher baseline creatine stores, fewer Type II muscle fibres, and less muscle mass. About 20-30% of people may be low responders.

How do I know if I am a creatine responder?

If you notice increased strength, weight gain of 1-3kg in the first week, and improved workout performance within 2-4 weeks, you are likely a responder. Vegetarians are almost always responders.

What percentage of people respond to creatine?

Approximately 70-80% of people are responders who show meaningful increases in muscle creatine. The remaining 20-30% show minimal response.